Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CALR Gene Mutation”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Early research (Phase 1)Looking for participantsNCT06034002
What this trial is testing

Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasms
Incyte Corporation 290
Early research (Phase 1)Study completedNCT03566446
What this trial is testing

CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasm, UnclassifiableEssential ThrombocythemiaMyelofibrosis
Inge Marie Svane 10
Large-scale testing (Phase 3)Active Not RecruitingNCT06514807
What this trial is testing

Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients

Who this might be right for
Essential Thrombocythaemia
AOP Orphan Pharmaceuticals AG 117
Not applicableUnknownNCT05123326
What this trial is testing

Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome

Who this might be right for
Hepatic Vein ThrombosesHepatic Venous Outflow ObstructionPortal Vein Thrombosis+7 more
Post Graduate Institute of Medical Education and Research, Chandigarh 300
Large-scale testing (Phase 3)Looking for participantsNCT07623200
What this trial is testing

INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

Who this might be right for
Essential Thrombocythemia
Incyte Corporation 426
Early research (Phase 1)Looking for participantsNCT07008118
What this trial is testing

Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasms
Incyte Corporation 120
Very early researchEnded earlyNCT03972943
What this trial is testing

CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia

Who this might be right for
CALR Gene MutationEssential ThrombocythemiaJAK2 Gene Mutation+3 more
University of Utah 8
Not applicableLooking for participantsNCT06480591
What this trial is testing

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Who this might be right for
Myeloproliferative Neoplasm
Wake Forest University Health Sciences 35
Early research (Phase 1)Active Not RecruitingNCT05936359
What this trial is testing

Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasms
Incyte Corporation 160